Year: 2010
Type: article
Abstract: The FDA has conducted a comprehensive review of the benefits and risks of using LABAs to treat asthma. Drs. Badrul Chowdhury and Gerald Dal Pan discuss the agency's conclusions.
Source: New England Journal of Medicine
DOI: 10.1056/nejmp1002074
Authors: Badrul A. Chowdhury, Gerald Dal Pan
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2056770521
